Elevated CD40 ligand expressing blood T-cell levels in multiple sclerosis are reversed by interferon-beta treatment

Scandinavian Journal of Immunology

Volumn 51, Issue 3, 2000, Pages 312-320

  Teleshova, N ^a   Bao, W ^a   Kivisakk P ^a   Ozenci V ^a   Mustafa, M ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CD40 ANTIGEN;

ADULT; ARTICLE; DEMYELINATING DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD14; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD40; ANTIGENS, CD8; CD4-CD8 RATIO; CD40 LIGAND; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INTERFERON-BETA; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; RECOMBINANT PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 0034071168     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00688.x     Document Type: Article

References (34)

1. Banchereau J, Bazan F, Blanchard D et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994;12:881-922.
2. Nishioka Y, Lipsky PE. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J Immunol 1994;153:1027-36.
3. Grewal IS, Flavell RA. The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 1996;153:85-106.
4. + T-cell responses. Immunol Today 1996;17:410-4.
5. Grewal IS, Foellmer HG, Grewal KD et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996;273:1864-7.
6. Van Kooten C, Banchereau J. Immune regulation by CD40-CD40L interactions. Front Biosci 1997;1:2: D1-D11.
7. Mackey MF, Barth RJJ, Noelle RJ. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 1998;63:418-28.
8. Snow EC, Vitetta ES, Uhr JW. Activation of antigen-enriched B cells. 1. Purification and response to thymus-independent antigens. J Immunol 1983;130:607-13.
9. Karmann K, Hughes C, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995;92:4342-6.
10. Hollenbaugh D, Mischel-Petty N, Edwards CP et al. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995;182:33-40.
11. MacDonald KPA, Nishioka Y, Lipsky PE, Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997;100:2404-14.
12. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996;97:2063-73.
13. Koshy M, Berger D, Crow M. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996;98:826-37.
14. Gerritse K, Laman JD, Noelle RJ et al. CD40-CD40 ligand interactions in experimental allergic encephalomyeltis and multiple sclerosis. Proc Natl Acad Sci USA 1996;93:2499-504.
15. Link H. B cells and autoimmunity. In: Russel WC. ed. Molecular Biology of Multiple Sclerosis. Chichester, UK: John Wiley & Sons, 1997,161-190.
16. Lopez-Moratalla N, Gonzalez A, Aymerich MS et al. Monocyte inducible nitric oxide synthase in multiple sclerosis: Regulatory role of nitric oxide. Nitric Oxide 1997;1:95-104.
17. Reder AT, Genc K, Byskosh PV, Porrini AM. Monocyte activation in multiple sclerosis. Multiple Sclerosis 1998;4:162-8.
18. + T cells via CD40L. Proc Natl Acad Sci USA 1997;94:599-603.
19. Poser JB, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-31.
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
21. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
22. Castle BE, Kishimoto K, Stearns C, Brown M, Kehry MR. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J Immunol 1993;151:1777-88.
23. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T-cell clones specific for myelin basic protein. Cell 1995;80:695-705.
24. Dalgleish AG. Viruses and multiple sclerosis. Acta Neurol Scand (Suppl) 1997;169:8-15.
25. Oldstone MB. Viruses and autoimmune diseases. Scand J Immunol 1997;46:320-5.
26. Rudick RA, Ransohoff RM. Biologic effects of interferons: Relevance to multiple sclerosis. Multiple Sclerosis 1995;1 (Suppl. 1):12-6.
27. Knobler RL, Panitch HS, Braheny SL et al. Clinical trial of natural alpha interferon in multiple sclerosis. Ann NY Acad Sci 1984; 436:382-8.
28. Noronha A, Toscas A, Jensen MA. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J Neuroimmunol 1993;46:145-53.
29. Rudick RA, Carpenter CS, Cookfair DL, Tuohy VK, Ransohoff RM. In vitro and vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta. Neurology 1993;43:2080-7.
30. Abu-Khabar KS, Armstrong JA, Ho M. Type I interferons (IFN-alpha and -beta) supress cytotoxin (tumour necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells. J Leukoc Biol 1992;52:165-72.
31. Rep MH, Hitzen RQ, Polman CH, van Lier RA. Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J Neuroimmunol 1996;67: 111-8.
32. Byskosh PV, Reder AT. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Multiple Sclerosis 1996;1:262-9.
33. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10188-92.
34. + T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260:547-9.